BioGeometry Unveils GeoFlow V4: Moving Beyond Binders to Drug-Ready Molecules

Scaling data and models has pushed GeoFlow to new heights in structure prediction, screening, and design. Now, we’re pairing it with GeoFlow Code—a programming language and execution framework built for agentic drug design. Together, they bridge models, molecules, and data into a closed loop of recursive self-improvement, accelerating end-to-end drug development.

Learn MoreBioGeometry Unveils GeoFlow V4: Moving Beyond Binders to Drug-Ready Molecules

BioGeometry Closes Series A Funding Rounds Totaling Over $100 Million,Toward Life Sciences Superintelligence with Self-Evolving World Models

The proceeds will primarily support the continued development of GeoFlow, at the molecular scale, and GeoCell, at the cellular scale, the company’s two biological world models; the expansion of automated high-throughput laboratories; and the advancement of its proprietary drug pipeline toward commercialization.

Learn MoreBioGeometry Closes Series A Funding Rounds Totaling Over $100 Million,Toward Life Sciences Superintelligence with Self-Evolving World Models

Load More